Skip to main content
BMC Cancer logoLink to BMC Cancer
. 2024 Mar 19;24:348. doi: 10.1186/s12885-024-12128-6

Correction: Apolipoprotein A-IV concentrations and cancer in a large cohort of chronic kidney disease patients: results from the GCKD study

Barbara Kollerits 1, Simon Gruber 1, Inga Steinbrenner 2, Johannes P Schwaiger 1, Hansi Weissensteiner 1, Sebastian Schönherr 1, Lukas Forer 1, Fruzsina Kotsis 2,5, Ulla T Schultheiss 2,5, Heike Meiselbach 3,4, Christoph Wanner 6, Kai-Uwe Eckardt 3,4,7, Florian Kronenberg 1,; for the GCKD Investigators
PMCID: PMC10949802  PMID: 38504160

Correction : BMC Cancer 24, 320 (2024)

10.1186/s12885-024-12053-8

Following publication of the original article [1], the author noticed an error in the affiliation of Inga Steinbrenner. Her affiliation should be 2, instead of affiliation 3.

The correct affiliation for Inga Steinbrenner is:

2Institute of Genetic Epidemiology, Faculty of Medicine and Medical Center—University of Freiburg, Freiburg, Germany.

The original article [1] has been corrected.

Reference

  • 1.Kollerits B, Gruber S, Steinbrenner I, et al. Apolipoprotein A-IV concentrations and cancer in a large cohort of chronic kidney disease patients: results from the GCKD study. BMC Cancer. 2024;24:320. doi: 10.1186/s12885-024-12053-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Cancer are provided here courtesy of BMC

RESOURCES